Health Insurance Coverage Limitations of Anti-Integrin Therapy in Ulcerative Colitis and Their Impact on Anti-Tumor Necrosis Factor (Anti-TNF) Therapy Utilization

被引：0
|
作者：
John, Eric [1 ]
机构：
[1] Spherix Global Insights, Exton, PA USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2021年 / 116卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S801
引用
收藏
页码：S371 / S371
页数：1
相关论文
共 50 条
  • [11] Association of persistence with anti-tumor necrosis factor (anti-TNF) therapy and healthcare costs in patients with psoriatic arthritis (PSA)
    Tang, Boxiong
    Meissner, B.
    Dabbous, Omar
    Rahman, Mirza
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (02) : AB122 - AB122
  • [12] Biological Therapy for Ulcerative Colitis: What is after Anti-TNF
    Fiorino, Gionata
    Cesarini, Monica
    Danese, Silvio
    CURRENT DRUG TARGETS, 2011, 12 (10) : 1433 - 1439
  • [13] Systematic review of efficacy of anti-tumor necrosis factor (TNF) therapy in patients with psoriasis previously treated with a different anti-TNF agent
    Yamauchi, Paul S.
    Bissonnette, Robert
    Teixeira, Henrique D.
    Valdecantos, Wendell C.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 75 (03) : 612 - +
  • [14] Infections and anti-tumor necrosis factor α therapy
    Ellerin, T
    Rubin, RH
    Weinblatt, ME
    ARTHRITIS AND RHEUMATISM, 2003, 48 (11): : 3013 - 3022
  • [15] Cutaneous manifestations of anti-tumor necrosis factor (anti-TNF) therapy in patients with inflammatory bowel disease (IBD): A case series
    Peer, F. C.
    Subramaniam, K.
    Pavli, P.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 108 - 108
  • [16] TREATMENT PATTERNS OF ANTI-TUMOR NECROSIS FACTOR AND ANTI-INTEGRIN THERAPIES IN INFLAMMATORY BOWEL DISEASE (IBD): ANALYSIS OF US INSURANCE CLAIMS
    Reddy, Sheila
    Chang, Eunice
    Tarbox, Marian
    Broder, Michael S.
    Best, Jennie
    Pan, Wayne
    GASTROENTEROLOGY, 2018, 154 (06) : S838 - S839
  • [17] Dysregulation of innate immunity in ulcerative colitis patients who fail anti-tumor necrosis factor therapy
    Baird, Angela C.
    Mallon, Dominic
    Radford-Smith, Graham
    Boyer, Julien
    Piche, Thierry
    Prescott, Susan L.
    Lawrance, Ian C.
    Tulic, Meri K.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (41) : 9104 - 9116
  • [18] Granulocyte-Monocyte Apheresis as an Adjuvant Therapy to Anti-Tumor Necrosis Factor Drugs for Ulcerative Colitis
    Rodriguez-Lago, Iago
    Gomez-Irwin, Laura
    Fernandez, Encarnacion
    Higuera, Rebeca
    Luis Cabriada, Jose
    THERAPEUTIC APHERESIS AND DIALYSIS, 2017, 21 (01) : 26 - 30
  • [19] Dysregulation of innate immunity in ulcerative colitis patients who fail anti-tumor necrosis factor therapy
    Angela C Baird
    Dominic Mallon
    Graham Radford-Smith
    Julien Boyer
    Thierry Piche
    Susan L Prescott
    Ian C Lawrance
    Meri K Tulic
    World Journal of Gastroenterology, 2016, (41) : 9104 - 9116
  • [20] Serological markers associated with disease behavior and response to anti-tumor necrosis factor therapy in ulcerative colitis
    Kevans, David
    Waterman, Matti
    Milgrom, Raquel
    Xu, Wei
    Van Assche, Gert
    Silverberg, Mark
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 (01) : 64 - 70
12345